Skip to content

Debt-to-equity at other companies

CVS Health logo
CVS HealthCVS
0.2×0.0×
Amazon logo
AmazonAMZN
0.5×0.0×
Doximity logo
DoximityDOCS
0.0×
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
127.9×+119×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
1.4×-0.2×
Cencora logo
CencoraCOR
3.6×-3.4×

Other financials

Income statement

See full
Revenue$194.0M-4.4%
Gross profit$173.9M-8.3%
Operating income$14.0M-40.1%
Net income$1.2M-89.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$235.7M-21.7%
Total debt$541.4M0.0%
Total equity$622.0M-4.9%
Total assets$2.0B+56.0%

Cash flow

See full
Operating cash flow$11.8M+25.8%
CapEx$1.1M+700%
Free cash flow$10.7M+15.4%

Valuation

See full
Market cap$934.74M-43.1%
Enterprise value$1.24B-34.1%
P/E45.5×-12.3×
P/S1.2×-0.9×

Profitability

See full
Gross margin91.8%-2.0pp
Operating margin9.9%-0.3pp
Net margin2.6%-1.0pp
FCF margin21%+2.3pp

Returns & leverage

See full
Return on equity3.2%-1.2pp
Current ratio1.5×-3.8×

Where this comes from

Calculated from GoodRx Holdings, Inc.’s reported figures.

Based on the most recent quarter.

The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about GoodRx Holdings, Inc.'s debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GoodRx Holdings, Inc.'s debt-to-equity?
GoodRx Holdings, Inc. (GDRX) reported debt-to-equity of 0.9× in Q1 2026.
How has GoodRx Holdings, Inc.'s debt-to-equity changed year-over-year?
GoodRx Holdings, Inc.'s debt-to-equity increased by 5.2% year-over-year, from 0.8× to 0.9×.
What is the long-term trend for GoodRx Holdings, Inc.'s debt-to-equity?
Over 5 years (2020 to 2025), GoodRx Holdings, Inc.'s debt-to-equity has grown at a -2.3% compound annual growth rate (CAGR), from 1× to 0.9×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.